Home > Balance Sheet > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹163 Cr₹170 Cr₹84 Cr₹88 Cr₹74 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA is ₹163 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹163 Cr
Mar2024₹170 Cr
Mar2023₹84 Cr
Mar2022₹88 Cr
Mar2021₹74 Cr

How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹163 Cr
-4.09
Mar2024 ₹170 Cr
101.52
Mar2023 ₹84 Cr
-4.05
Mar2022 ₹88 Cr
18.79
Mar2021 ₹74 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,250.8 Cr 0.1% 12.6% 24.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹388,680.0 Cr 0.3% -3.7% -4.7% Stock Analytics
DIVIS LABORATORIES ₹168,817.0 Cr 2.4% 6.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,297.0 Cr -0.8% -1.5% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹109,828.0 Cr 7.9% 4.6% 4.6% Stock Analytics
CIPLA ₹104,588.0 Cr 5.5% 5.4% -18.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.1%

12.6%

24.2%

SENSEX

-2.3%

3.3%

-2.4%


You may also like the below Video Courses